← Open Payments lookup

CHELSEA GREENWOOD: Open Payments

NPI 1740063890 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,796 in 88 payments from 21 companies in 2025. Trend: 2023 $33 · 2024 $1,677 · 2025 $1,796

Food & beverage: $1,796
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$325
ABBVIE INC.16$258
Novo Nordisk Inc10$162
PFIZER INC.6$125
Sumitomo Pharma America, Inc.5$124
GlaxoSmithKline, LLC.6$116
Amgen Inc.6$98
Aimmune Therapeutics, Inc.4$95
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$67
Corcept Therapeutics2$61

Products named: BREZTRI, GEMTESA, TRELEGY ELLIPTA, ELIQUIS, ZENPEP, VRAYLAR, AIRSUPRA, LINZESS.

Industry payments across AZ — which companies pay providers there.